Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2510.0000 (-3.09%) ($2510.0000 - $2585.0000) on Tue. May. 27, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 27 | Latest Price | $2510.0000(-3.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | Factors Impacting CAPR price | CAPR will decline at least -1.305% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
Resistance Level | $2668.95 | 5 Day Moving Average | $2557.99(-1.88%) | 10 Day Moving Average | $2619.5(-4.18%) | 20 Day Moving Average | $2668.95(-5.96%) | To recent high | -7.9% | To recent low | 14.1% | Market Cap | $49.441b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |